{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:04:29Z","timestamp":1771916669072,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,23]]},"DOI":"10.7759\/cureus.104148","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:11:11Z","timestamp":1771902671000},"source":"Crossref","is-referenced-by-count":0,"title":["Unprovoked Deep Vein Thrombosis as a Manifestation of Cushing's Disease"],"prefix":"10.7759","author":[{"given":"Sharini","family":"Venugopal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maunank","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0569-6","article-title":"Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States","volume":"18","author":"Broder MS","year":"2015","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients &lt;65 years old in the United States. Pituitary. 2015, 18:283-9. 10.1007\/s11102-014-0569-6","journal-title":"Pituitary"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101496","article-title":"Hypercoagulability in Cushing's syndrome: from arterial to venous disease","volume":"35","author":"St-Jean M","year":"2021","unstructured":"St-Jean M, Lim DS, Langlois F. Hypercoagulability in Cushing's syndrome: from arterial to venous disease. Best Pract Res Clin Endocrinol Metab. 2021, 35:101496. 10.1016\/j.beem.2021.101496","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland MJ","year":"2011","unstructured":"Bolland MJ, Holdaway IM, Berkeley JE, et al.. Mortality and morbidity in Cushing's syndrome in New Zealand. Clin Endocrinol (Oxf). 2011, 75:436-42. 10.1111\/j.1365-2265.2011.04124.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343697","article-title":"Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome","volume":"23","author":"Fatti LM","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest. 2000, 23:145-50. 10.1007\/BF03343697","journal-title":"J Endocrinol Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvz033","article-title":"Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez MG","year":"2020","unstructured":"Suarez MG, Stack M, Hinojosa-Amaya JM, et al.. Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study. J Endocr Soc. 2020, 4:bvz033. 10.1210\/jendso\/bvz033","journal-title":"J Endocr Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing's syndrome: a systematic review","volume":"94","author":"Van Zaane B","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, et al.. Hypercoagulable state in Cushing's syndrome: a systematic review. J Clin Endocrinol Metab. 2009, 94:2743-50. 10.1210\/jc.2009-0290","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers OM","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JO, et al.. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab. 2013, 98:2277-84. 10.1210\/jc.2012-3582","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0914-9","article-title":"The degree of urinary hypercortisolism is not correlated with the severity of Cushing's syndrome","volume":"55","author":"Guarnotta V","year":"2017","unstructured":"Guarnotta V, Amato MC, Pivonello R, et al.. The degree of urinary hypercortisolism is not correlated with the severity of Cushing's syndrome. Endocrine. 2017, 55:564-72. 10.1007\/s12020-016-0914-9","journal-title":"Endocrine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis","volume":"9","author":"Wagner J","year":"2019","unstructured":"Wagner J, Langlois F, Lim DS, McCartney S, Fleseriu M. Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis. Front Endocrinol (Lausanne). 2019, 9:805. 10.3389\/fendo.2018.00805","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0997","article-title":"Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN","volume":"178","author":"Valassi E","year":"2018","unstructured":"Valassi E, Franz H, Brue T, et al.. Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. Eur J Endocrinol. 2018, 178:399-409. 10.1530\/EJE-17-0997","journal-title":"Eur J Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0600-y","article-title":"Perioperative thromboprophylaxis in Cushing's disease: what we did and what we are doing?","volume":"18","author":"Barbot M","year":"2015","unstructured":"Barbot M, Daidone V, Zilio M, et al.. Perioperative thromboprophylaxis in Cushing's disease: what we did and what we are doing?. Pituitary. 2015, 18:487-93. 10.1007\/s11102-014-0600-y","journal-title":"Pituitary"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1669-2","article-title":"Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease","volume":"62","author":"Barbot M","year":"2018","unstructured":"Barbot M, Guarnotta V, Zilio M, et al.. Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease. Endocrine. 2018, 62:207-14. 10.1007\/s12020-018-1669-2","journal-title":"Endocrine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"Isidori AM","year":"2015","unstructured":"Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB. Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol. 2015, 173:R101-13. 10.1530\/EJE-15-0308","journal-title":"Eur J Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi G","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, et al.. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003, 88:5593-602. 10.1210\/jc.2003-030871","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2753","article-title":"The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy","volume":"97","author":"van der Pas R","year":"2012","unstructured":"van der Pas R, de Bruin C, Leebeek FW, et al.. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab. 2012, 97:1303-10. 10.1210\/jc.2011-2753","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02320-x","article-title":"Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)","volume":"17","author":"van Haalen FM","year":"2022","unstructured":"van Haalen FM, Kaya M, Pelsma IC, et al.. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet J Rare Dis. 2022, 17:178. 10.1186\/s13023-022-02320-x","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0665-z","article-title":"A venous thromboembolism risk assessment model for patients with Cushing's syndrome","volume":"52","author":"Zilio M","year":"2016","unstructured":"Zilio M, Mazzai L, Sartori MT, et al.. A venous thromboembolism risk assessment model for patients with Cushing's syndrome. Endocrine. 2016, 52:322-32. 10.1007\/s12020-015-0665-z","journal-title":"Endocrine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341739-unprovoked-deep-vein-thrombosis-as-a-manifestation-of-cushings-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:11:14Z","timestamp":1771902674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341739-unprovoked-deep-vein-thrombosis-as-a-manifestation-of-cushings-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.104148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,23]]}}}